CLINICAL_TRIALS
trial_result
· 2015-03-11
Clinical Trial Update: Curcumin (Tumeric) in the Treatment of Irritable Bowel Syndrome: A Randomized-Controlled Trial [Phase 4]
Summary
A Phase 4 randomized controlled trial evaluating curcumin (turmeric) for irritable bowel syndrome has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Kaiser Permanente | Conditions: Irritable Bowel Syndrome | Phase 4 | Status: COMPLETED